Borse, dividendi mondiali oltre i «rumori di fondo»: primo trimestre da record
di Maximilian Cellino
In the three-year period from 2022 to 2024, public healthcare expenditure will grow steadily in nominal terms, but inflation will reduce real growth to just over 1 per cent, in a context of substantial stability in relation to GDP. Together with "structural rigidities" and "strong territorial inhomogeneities" on the one hand, and - on the other - the need to "accelerate Pnrr investments" that are marking time especially on the front of care closer to citizens with houses and community hospitals still largely to be built, this is the figure of the Corte dei Conti's Report to Parliament on the management of regional health services, for the 2023-2024 financial years.
The accounting magistrates therefore describe a post-pandemic National Health System 'still marked by strong territorial inhomogeneities and managerial criticalities, albeit on the way to a consolidation phase'. And whose future 'will depend on the ability to transform the nominal increase in expenditure into an actual improvement in services, strengthening territorial equity, digitalisation, proximity and sustainability'.
From the Report approved by the Autonomies Section (Resolution no. 21/SEZAUT/FRG/2025), it emerges the increase from €131.3 to €138.3 billion in public health expenditure for the three-year period 2022-2024, with a growth of 4.9% over 2023 (5.4% over 2022) and the maintenance of a stable incidence on GDP (6.3-6.4%, against a European average of 6.9%). The increase "is driven by expenditure items related to personnel (+5.6%) and intermediate consumption (+7.5%)", but "reduced to a real increase of just over 1% due to inflation, highlighting an expenditure dynamic that is more defensive than expansive".
As in previous years, Italy's public healthcare expenditure in 2024 is significantly lower than the average of its European partners, both in per capita value and as a percentage of GDP. The level of Italian expenditure "is in fact conditioned by more stringent public finance constraints, given the large size of the debt", the Court further notes.
'The general trend,' is the observation, 'is one of stabilising post-pandemic funding, with the risk of implementing a healthcare spending model aimed at preserving the existing, rather than enhancing capacity and services'.